By Ariel Schwartz
Take a trip to the Autodesk Gallery in San Francisco and you'll see all manner of products that have been helped along with the company's design software--the electric Pi Cycle bike, a 3D-HD autostereoscopic display, a model of the new Bay Bridge span, and more. One day, that gallery might include human organs.
Autodesk recently announced that it's teaming up with bioprinting company Organovo to develop software that can design human tissue to be printed out on 3-D printers. In the near future, the printed organs are expected to be used in research. But down the line, they could end up inside real, live humans--an alternative to today's inefficient organ donation process.
Organovo is known for creating the first commercial 3-D bioprinters back in 2010; as of September 2012, the company had produced 10 bioprinters, each of which reportedly costs hundreds of thousands of dollars. Created with technology from biophysicist Gabor Forgacs (he's also the co-founder of test tube meat and leather startup Modern Meadow--and the father of the other cofounder, Andras Forgacs), Organovo's NovoGen MMX Bioprinter shapes cells--often stem cells from a donor--into 3-D tissue that's theoretically as good as anything created by the human body. Clinical testing is still years away.
The partnership with Autodesk isn't completely unexpected. Autodesk's Bio/Nano Programmable Matter research group collaborates with outside researchers on design software's role in biotechnology.
Hod Lipson, head of Cornell's Creative Machines Lab, explained the need for design software in organ printing in a Wall Street Journalarticle: "We have machines that can make almost anything, but we don't have the design tools," he said. "In bioprinting, there is no computer-aided design software for body parts."
As surgeon Anthony Atala demonstrated on the TED stage in 2011, printable organs really aren't that far from becoming reality (as long as the FDA doesn't get in the way). Body part design software only speeds up the process.
Copyright 2013 by Fast Company. Reprinted with permission.